Antitrust storm in the pharmaceutical sector: Government departments in many places have been accused of abusing administrative power
Recently, the competitive order in the pharmaceutical field has been severely challenged again. The Shaanxi Provincial Market Supervision Bureau officially launched an investigation into the Hanyin County People's Government because of the obvious tendency of geographical protection in the policy documents issued by it, which restricted fair competition of products from other places. This incident quickly aroused widespread concern from all walks of life.
In Suihua City, similar problems have surfaced. The local health commission's designation of an insurance company as the exclusive partner and the designation of a specific agency in the settlement of medical disputes was questioned as an abuse of administrative power to eliminate and restrict market competition.
These cases are just the tip of the iceberg. In the field of medicine, it is not uncommon to abuse administrative power and monopolize the market through cooperation agreements. These behaviors not only seriously disrupt the order of fair competition in the market, but also hinder the healthy development of the industry.
Specifically, some local government departments provide unfair competitive advantages for specific enterprises in the procurement and distribution of drugs, consumables, equipment and equipment by formulating policies and signing agreements. This "government-enterprise cooperation" model allows some companies to easily gain market share, while others are excluded.
In order to maintain a level playing field in the pharmaceutical market, the state and local government departments are taking active actions. The State Administration for Market Regulation (SAMR) has notified a number of abuses of administrative power to eliminate or restrict competition, and has imposed penalties on relevant government departments. At the same time, various localities have also carried out special anti-monopoly law enforcement actions, focusing on cracking down on monopolistic behaviors in the pharmaceutical field.
The implementation of these measures indicates the importance and determination of the state to the anti-monopoly work in the pharmaceutical field. In the future, with the continuous strengthening of supervision and law enforcement, it is believed that the competition order in the pharmaceutical field will gradually move towards standardization and fairness.
However, to achieve this goal, all parties need to work together. Government departments need to further strengthen supervision and enforcement to ensure the fairness and impartiality of policy documents; Enterprises need to consciously abide by the rules of market competition and abandon unfair competition; Consumers also need to raise their awareness of self-protection and choose formal channels to purchase drugs and medical devices.
In short, there is a long way to go in anti-monopoly work in the pharmaceutical field. Only by making joint efforts and forming a joint force can we create a market environment of fair competition and healthy development.
The material comes from the Internet, invaded and deleted!